RxDoctor Payments DataLook up a doctor →

NEXLIZET: payments to doctors

Payments that named NEXLIZET as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$10.3M
Providers
11,586
Transactions
25,071
Average per transaction
$410

The per-transaction average — $410 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,586 providers the average total is $887, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Esperion Therapeutics, Inc.$10,251,08599.7%
Currax Pharmaceuticals LLC$29,4020.3%
← All drugs & devices